Advertisement

Index by author

July 01, 1996; Volume 50,Issue 1

A

  1. Ahluwalia, G S

    1. 2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
      G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
      Molecular Pharmacology July 1996, 50 (1) 160-165;

  2. Akerman, G

    1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;

  3. Almaula, N

    1. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;

  4. Angelotti, T P

    1. Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;

B

  1. Baker, S P

    1. A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;

  2. Ballesteros, J A

    1. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;

  3. Barone, L

    1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;

  4. Barwick, J L

    1. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

  5. Bayard, F

    1. Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;

  6. Beavers, L

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

  7. Behrends, S

    1. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;

  8. Belardinelli, L

    1. A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;

  9. Bhattacharya, S

    1. Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
      S Bhattacharya and J Linden
      Molecular Pharmacology July 1996, 50 (1) 104-111;

  10. Boissard, C G

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  11. Browning, M D

    1. Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;

  12. Bruno, V

    1. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;

  13. Burgard, E C

    1. Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
      E C Burgard, E I Tietz, T R Neelands and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 119-127;

C

  1. Canonico, P L

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

  2. Cavallaro, S

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

  3. Chance, R E

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

  4. Chavkin, C

    1. k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release.
      M L Simmons and C Chavkin
      Molecular Pharmacology July 1996, 50 (1) 80-85;

  5. Cheng, E

    1. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;

  6. Cline, R T

    1. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;

  7. Copani, A

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

  8. Criscimagna, N L

    1. B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
      S A Mathis, N L Criscimagna and L M Leeb-Lundberg
      Molecular Pharmacology July 1996, 50 (1) 128-139;

D

  1. D'Agata, V

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

  2. Delarue, F

    1. Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;

  3. Dubocovich, M L

    1. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
      P A Witt-Enderby and M L Dubocovich
      Molecular Pharmacology July 1996, 50 (1) 166-174;

  4. Dudek, E M

    1. Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;

  5. Dworetzky, S I

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

E

  1. Ebersole, B J

    1. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;

  2. Esbenshade, T A

    1. Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
      H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
      Molecular Pharmacology July 1996, 50 (1) 175-184;

F

  1. Faye, J C

    1. Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;

  2. Fraser, C M

    1. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;

G

  1. Gadski, R

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

  2. Gao, W Y

    1. 2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
      G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
      Molecular Pharmacology July 1996, 50 (1) 160-165;

  3. García-Sáinz, J A

    1. Effect of phorbol myristate acetate on alpha 1-adrenergic action in cells expressing recombinant alpha 1-adrenoceptor subtypes.
      J Vázquez-Prado and J A García-Sáinz
      Molecular Pharmacology July 1996, 50 (1) 17-22;

  4. Gehlert, D R

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

  5. Geoghagen, N S

    1. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;

  6. Gonzalez, F J

    1. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;

  7. Gorski, J C

    1. Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;

  8. Grayson, D R

    1. Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
      W J Zhu, J F Wang, S Vicini and D R Grayson
      Molecular Pharmacology July 1996, 50 (1) 23-33;

  9. Gribkoff, V K

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  10. Guerrero, S W

    1. Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
      H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
      Molecular Pharmacology July 1996, 50 (1) 175-184;

  11. Guzelian, P S

    1. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

H

  1. Haehner, B D

    1. Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;

  2. Hall, S D

    1. Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;

  3. Hoffman, J A

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

I

  1. Ikeda, H

    1. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
      M Yoshimura, H Ikeda and B Tabakoff
      Molecular Pharmacology July 1996, 50 (1) 43-51;

J

  1. Janardan, S K

    1. Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;

  2. Johns, D G

    1. 2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
      G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
      Molecular Pharmacology July 1996, 50 (1) 160-165;

K

  1. Koesling, D

    1. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;

  2. Kozlowski, E S

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

L

  1. Lakhlani, P P

    1. Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
      P P Lakhlani, D M Lovinger and L E Limbird
      Molecular Pharmacology July 1996, 50 (1) 96-103;

  2. Larhammar, D

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

  3. Lee, N H

    1. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
      N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser
      Molecular Pharmacology July 1996, 50 (1) 140-148;

  4. Lee, S S

    1. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;

  5. Leeb-Lundberg, L M

    1. B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
      S A Mathis, N L Criscimagna and L M Leeb-Lundberg
      Molecular Pharmacology July 1996, 50 (1) 128-139;

  6. Limbird, L E

    1. Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
      P P Lakhlani, D M Lovinger and L E Limbird
      Molecular Pharmacology July 1996, 50 (1) 96-103;

  7. Lin, Y F

    1. Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;

  8. Linden, J

    1. Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
      S Bhattacharya and J Linden
      Molecular Pharmacology July 1996, 50 (1) 104-111;

  9. Lovinger, D M

    1. Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
      P P Lakhlani, D M Lovinger and L E Limbird
      Molecular Pharmacology July 1996, 50 (1) 96-103;

  10. Lum-Ragan, J T

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  11. Lundell, I

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

M

  1. Macdonald, R L

    1. Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
      E C Burgard, E I Tietz, T R Neelands and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 119-127;
    2. Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
      Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 185-195;

  2. Marinozzi, M

    1. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;

  3. Mathis, S A

    1. B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
      S A Mathis, N L Criscimagna and L M Leeb-Lundberg
      Molecular Pharmacology July 1996, 50 (1) 128-139;

  4. Mayer, B

    1. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;

  5. Mckay, M C

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  6. Meanwell, N A

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  7. Mesange, F

    1. Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;

  8. Mills, A S

    1. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

  9. Minneman, K P

    1. Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
      H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
      Molecular Pharmacology July 1996, 50 (1) 175-184;

  10. Mitsuya, H

    1. 2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
      G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns
      Molecular Pharmacology July 1996, 50 (1) 160-165;

  11. Monks, A

    1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;

  12. Montali, J A

    1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;

  13. Munson, P J

    1. KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
      G E Rovati, R Shrager, S Nicosia and P J Munson
      Molecular Pharmacology July 1996, 50 (1) 86-95;

  14. Musco, S

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

N

  1. Neelands, T R

    1. Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
      E C Burgard, E I Tietz, T R Neelands and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 119-127;

  2. Nicoletti, F

    1. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;

  3. Nicosia, S

    1. KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
      G E Rovati, R Shrager, S Nicosia and P J Munson
      Molecular Pharmacology July 1996, 50 (1) 86-95;

P

  1. Pellicciari, R

    1. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;

  2. Peters, J M

    1. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;

  3. Petralia, S

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

  4. Post-Munson, D J

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  5. Potenza, C

    1. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

  6. Puel, J

    1. Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
      F Mesange, F Delarue, J Puel, F Bayard and J C Faye
      Molecular Pharmacology July 1996, 50 (1) 75-79;

Q

  1. Quattrochi, L C

    1. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

R

  1. Ram, P A

    1. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;

  2. Romine, J L

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  3. Rosser, D

    1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;

  4. Rovati, G E

    1. KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
      G E Rovati, R Shrager, S Nicosia and P J Munson
      Molecular Pharmacology July 1996, 50 (1) 86-95;

  5. Ruble, J

    1. A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;

S

  1. Scammells, P J

    1. A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;

  2. Schmidt, D E

    1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;

  3. Schmidt, K

    1. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;

  4. Schober, D A

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

  5. Schrammel, A

    1. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
      A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
      Molecular Pharmacology July 1996, 50 (1) 1-5;

  6. Sealfon, S C

    1. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;

  7. Shrager, R

    1. KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
      G E Rovati, R Shrager, S Nicosia and P J Munson
      Molecular Pharmacology July 1996, 50 (1) 86-95;

  8. Shryock, J C

    1. A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;

  9. Simmons, M L

    1. k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release.
      M L Simmons and C Chavkin
      Molecular Pharmacology July 1996, 50 (1) 80-85;

  10. Smiley, D L

    1. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
      D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar
      Molecular Pharmacology July 1996, 50 (1) 112-118;

  11. Srinivas, M

    1. A novel irreversible antagonist of the A1-adenosine receptor.
      M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli
      Molecular Pharmacology July 1996, 50 (1) 196-205;

  12. Starrett, J E

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  13. Stivala, F

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

T

  1. Tabakoff, B

    1. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
      M Yoshimura, H Ikeda and B Tabakoff
      Molecular Pharmacology July 1996, 50 (1) 43-51;

  2. Tew, K D

    1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;

  3. Thomsen, C

    1. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
      C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari
      Molecular Pharmacology July 1996, 50 (1) 6-9;

  4. Tietz, E I

    1. Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
      E C Burgard, E I Tietz, T R Neelands and R L Macdonald
      Molecular Pharmacology July 1996, 50 (1) 119-127;

  5. Travali, S

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

  6. Trojnacki, J T

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  7. Tukey, R H

    1. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
      J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian
      Molecular Pharmacology July 1996, 50 (1) 10-16;

V

  1. Vandenbranden, M

    1. Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;

  2. Vázquez-Prado, J

    1. Effect of phorbol myristate acetate on alpha 1-adrenergic action in cells expressing recombinant alpha 1-adrenoceptor subtypes.
      J Vázquez-Prado and J A García-Sáinz
      Molecular Pharmacology July 1996, 50 (1) 17-22;

  3. Ventra, C

    1. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
      S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico
      Molecular Pharmacology July 1996, 50 (1) 60-66;

  4. Vicini, S

    1. Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
      W J Zhu, J F Wang, S Vicini and D R Grayson
      Molecular Pharmacology July 1996, 50 (1) 23-33;

W

  1. Wang, J F

    1. Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
      W J Zhu, J F Wang, S Vicini and D R Grayson
      Molecular Pharmacology July 1996, 50 (1) 23-33;

  2. Watkins, P B

    1. Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;

  3. Waxman, D J

    1. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;

  4. Weinstein, H

    1. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
      N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon
      Molecular Pharmacology July 1996, 50 (1) 34-42;

  5. Wheatley, J B

    1. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
      K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt
      Molecular Pharmacology July 1996, 50 (1) 149-159;

  6. Witt-Enderby, P A

    1. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
      P A Witt-Enderby and M L Dubocovich
      Molecular Pharmacology July 1996, 50 (1) 166-174;

  7. Wrighton, S A

    1. Bimodal distribution of renal cytochrome P450 3A activity in humans.
      B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall
      Molecular Pharmacology July 1996, 50 (1) 52-59;

Y

  1. Yoshimura, M

    1. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
      M Yoshimura, H Ikeda and B Tabakoff
      Molecular Pharmacology July 1996, 50 (1) 43-51;

Z

  1. Zhong, H

    1. Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
      H Zhong, S W Guerrero, T A Esbenshade and K P Minneman
      Molecular Pharmacology July 1996, 50 (1) 175-184;

  2. Zhong, J

    1. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
      V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky
      Molecular Pharmacology July 1996, 50 (1) 206-217;

  3. Zhou, Y C

    1. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
      J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman
      Molecular Pharmacology July 1996, 50 (1) 67-74;

  4. Zhu, W J

    1. Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
      W J Zhu, J F Wang, S Vicini and D R Grayson
      Molecular Pharmacology July 1996, 50 (1) 23-33;
Back to top

In this issue